NA
Preclinical AI drug discovery and development platform
臨床前人工智慧藥物發現與開發平台
An AI platform designs novel and effective compounds with easy synthesis, screens potential protein targets, and validates with experiments, providing rigorous services to customers.
人工智慧平台設計新穎、有效、易於合成的化合物，篩選潛在的蛋白質標靶，並透過實驗進行驗證，為客戶提供嚴謹的服務。
未定中標題
Targeted indication
Status
Key features
Market
Targeted indication
1. Cancer
2. Alzheimer's disease
Status
Preclinical
Key features
- Key Features: To provide novel, effective, easy synthesis compounds
Market
MODE OF ACTION
EXPERIMENTAL RESULTS
in vitro efficacy
in vivo efficacy
INTELLECTUAL PROPERTY
Trade secret to protect our AI platform’s method and programming.
CONTACT
Shu-Tzu, Yeh szyeh914@biip-dcc.org